The DOI matches its Crossref record; 327 of the 327 references it cites were found in a registry or an index.
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Open accessAbstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age and is associated with various metabolic perturbations, in addition to chronic anovulation and factors related to androgen excess. In general, women live longer than men and develop cardiovascular disease at an older age. However, women with PCOS, as compared with age- and body mass index-matched women without the syndrome, appear to have a higher risk of insulin resistance, hyperinsulinemia, glucose intolerance, dyslipidemia, and an increased prothrombotic state, possibly resulting in a higher rate of type 2 diabetes mellitus, fatty liver disease, subclinical atherosclerosis, vascular dysfunction, and finally cardiovascular disease and mortality. Further alterations in PCOS include an increased prevalence of sleep apnea, as well as various changes in the secretion and/or function of adipokines, adipose tissue-derived proinflammatory factors and gut hormones, all of them with direct or indirect influences on the complex signaling network that regulates metabolism, insulin sensitivity, and energy homeostasis. Reviews on the cardiometabolic aspects of PCOS are rare, and our knowledge from recent studies is expanding rapidly. Therefore, it is the aim of the present review to discuss and to summarize the current knowledge, focusing on the alterations of cardiometabolic factors in women with PCOS. Further insight into this network of factors may facilitate finding therapeutic targets that should ameliorate not only ovarian dysfunction but also the various cardiometabolic alterations related to the syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–327 of 327
Villuendas, G., Millán, J. L. S., Sancho, J., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8309 · Cited by 119
The Plasma Homocysteine Levels Are Increased in Polycystic Ovary Syndrome
Loverro, G., Lorusso, F., Mei, L., Depalo, R., Cormio, G., & Selvaggi, L. E. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000058367 · Cited by 119
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 118
Self-citationDecreased Plsma Visfatin Concentrations in Women With Gestational Diabetes Mellitus
Chan, T., Chen, Y., Lee, C., Chou, F., Wu, L.-C., Jong, S., & Tsai, E. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2006.04.007 · Cited by 115
Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
Weiner, R. A. (2010) · Digestive Diseases · doi:10.1159/000282102 · Cited by 113
Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
Carmina, E. (2004) · PubMed · Cited by 112
Palomba, S., Falbo, A., Giallauria, F., Russo, T., Rocca, M., Tolino, A., Zullo, F., & Orio, F. (2010) · Human Reproduction · doi:10.1093/humrep/deq254 · Cited by 111
An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome
Brzozowska, M. M., Ostapowicz, G., & Weltman, M. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05740.x · Cited by 110
Polycystic ovary syndrome: A risk for coronary artery disease?
Wild, R. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119180 · Cited by 109
Abnormal aminotransferase activity in women with polycystic ovary syndrome
Schwimmer, J. B., Khorram, O., Chiu, V. Y., & Schwimmer, W. B. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.08.020 · Cited by 107
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome
Orio, F., Matarese, G., Biase, S. D., Palomba, S., Labella, D., Sanna, V., Savastano, S., Zullo, F., Colao, A., & Lombardi, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021816 · Cited by 106
Rajendran, S., Willoughby, S. R., Chan, W. P. A., Liberts, E. A., Heresztyn, T., Saha, M., Marber, M. S., Norman, R. J., & Horowitz, J. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.010 · Cited by 104
Tan, B. K., Chen, J., Digby, J. E., Keay, S. D., Kennedy, C. R., & Randeva, H. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0936 · Cited by 103
Self-citationSerum and adipocyte resistin in polycystic ovary syndrome with insulin resistance
Seow, K. (2003) · Human Reproduction · doi:10.1093/humrep/deh010 · Cited by 102
Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome
BROWN, A. J., SETJI, T. L., SANDERS, L. L., LOWRY, K. P., OTVOS, J. D., KRAUS, W. E., & SVETKEY, P. L. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31818c6c0c · Cited by 101
Halperin, I. J., Kumar, S. S., Stroup, D. F., & Laredo, S. (2010) · Human Reproduction · doi:10.1093/humrep/deq301 · Cited by 100
Peral, B., Millán, J. L. S., Castello, R., Moghetti, P., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8715 · Cited by 99
Legro, R. S., Zaino, R. J., Demers, L. M., Kunselman, A. R., Gnatuk, C. L., Williams, N. I., & Dodson, W. C. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.12.025 · Cited by 99
Association of Polymorphisms in the Interleukin 6 Receptor Complex with Obesity and Hyperandrogenism
Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & Millán, J. L. S. (2003) · Obesity Research · doi:10.1038/oby.2003.136 · Cited by 97
Erbey, J. R., Silberman, C., & LYDICK, E. G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00602-1 · Cited by 95
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
Berneis, K., Rizzo, M., Hersberger, M., Rini, G. B., Di Fede, G., Pepe, I., Spinas, G. A., & Carmina, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01897.x · Cited by 94
Zulian, E., Sartorato, P., Benedini, S., Baro, G., Armanini, D., Mantero, F., & Scaroni, C. M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345529 · Cited by 92
The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome
Wild, R. A., & Bartholomew, M. J. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80099-1 · Cited by 92
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls
Dejager, S., Pichard, C., Giral, P., Bruckert, É., Federspield, M. C., Beucler, I., & Turpin, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01245.x · Cited by 91
Pivovarova‐Ramich, O., Gögebakan, Ö., Klöting, N., Sparwaßer, A., Weickert, M. O., Haddad, I., Nikiforova, V. J., Bergmann, A., Kruse, M., Seltmann, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2839 · Cited by 91
Self-citationLeo, V. D., Musacchio, M. C., Piomboni, P., Sabatino, A. D., & Morgante, G. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.024 · Cited by 90
Ibáñez, L., de Zegher, F., & Potau, N. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350781 · Cited by 88
Increased plasma visfatin concentrations in women with polycystic ovary syndrome
Chan, T., Chen, Y., Chen, H.-H., Lee, C., Jong, S., & Tsai, E. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.120 · Cited by 87
Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans
von Loeffelholz, C., Möhlig, M., Arafat, A. M., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0737 · Cited by 87
Insulin Resistance and Impaired Insulin Secretion in Prenatally Androgenized Male Rhesus Monkeys
Bruns, C. M., Baum, S. T., Colman, R. J., Eisner, J. R., Kemnitz, J. W., Weindruch, R. H., & Abbott, D. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0918 · Cited by 87
Mather, K. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1851 · Cited by 87
Cardiometabolic features of polycystic ovary syndrome
Hoffman, L., & Ehrmann, D. A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0755 · Cited by 85
Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome
Orio, F., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Vuolo, L., Russo, T., Tolino, A., Lombardi, G., Colao, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0216 · Cited by 84
Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome
Palomba, S., Falbo, A. I., Russo, T., Manguso, F., Tolino, A., Zullo, F., Feo, P. D., & Orio, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0441 · Cited by 80
Vgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A. M., Kales, A., & Chrousos, G. P. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200107000-00017 · Cited by 80
Soares, G. M., Vieira, C. S., Martins, W. P., Franceschini, S. A., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03506.x · Cited by 79
Moro, C., Pasarica, M., Elkind-Hirsch, K. E., & Redman, L. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0051 · Cited by 79
Insulin-Lowering Drugs In Polycystic Ovary Syndrome
Iuorno, M. J., & Nestler, J. E. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70191-1 · Cited by 79
Self-citationSabuncu, T., Harma, M., Harma, M., Nazligul, Y., & Kilic, F. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)02162-9 · Cited by 78
JOHNSON, N. P., Stewart, A., Falkiner, J., Farquhar, C. M., Milsom, S. R., Singh, V. P., Okonkwo, Q. L., & Buckingham, K. (2010) · Human Reproduction · doi:10.1093/humrep/deq100 · Cited by 78
Cardiovascular risk factors in young Czech females with polycystic ovary syndrome
Vrbíková, J. (2003) · Human Reproduction · doi:10.1093/humrep/deg218 · Cited by 77
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome
Essah, P. A., Nestler, J. E., & Carmina, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345564 · Cited by 74
Self-citationOrt, T., Arjona, A. A., MacDougall, J. R., Nelson, P. J., Rothenberg, M. E., Wu, F. S.-Y., Eisen, A., & Halvorsen, Y. C. (2005) · Endocrinology · doi:10.1210/en.2004-1421 · Cited by 74
Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective
Nestler, J. E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.073 · Cited by 71
Self-citationTreatment of atypical endometrial hyperplasia with an insulin-sensitizing agent
Session, D. R., Kalli, K. R., Tummon, I. S., Damario, M. A., & Dumesic, D. A. (2003) · Gynecological Endocrinology · doi:10.1080/09513590312331290298 · Cited by 71
Conway, G. S., Avey, C., & Rumsby, G. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138773 · Cited by 71
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Alexandraki, K., & Panidis, D. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02693.x · Cited by 69
Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
Ozkaya, M., Cakal, E., Ustun, Y., & Engin-Ustun, Y. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.058 · Cited by 67
Horejsi, R., Möller, R., Rackl, S., Giuliani, A., Freytag, U., Crailsheim, K., Sudi, K. M., & Tafeit, E. (2003) · American Journal of Physical Anthropology · doi:10.1002/ajpa.10364 · Cited by 67
Chen, M., Chiu, H., Chen, C.-L., Yang, W., Yang, Y., & Ho, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2698 · Cited by 66
Kelly, C. J. G., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J., Rumley, A., Lowe, G. D. O., & Sattar, N. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8634 · Cited by 66
Self-citationSchahin, S. P., Nechanitzky, T., Dittel, C., Fuchs, F. S., Hahn, E. G., Konturek, P. C., Ficker, J. H., & Harsch, I. A. (2008) · PubMed · Cited by 66
Tang, T. H., Glanville, J., Hayden, C. J., White, D. M., Barth, J. H., & Balen, A. H. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197800.07214.dc · Cited by 65
Svendsen, P. F., Nilas, L., Madsbad, S., & Holst, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.009 · Cited by 65
Lifestyle Modification as the Primary Treatment of NASH
Neuschwander‐Tetri, B. A. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.006 · Cited by 63
Brown, A. J., Tendler, D. A., McMurray, R. G., & Setji, T. L. (2005) · Endocrine Practice · doi:10.4158/ep.11.5.319 · Cited by 63
Mai, K., Bobbert, T., Reinecke, F., Andres, J., Maser‐Gluth, C., Wudy, S. A., Möhlig, M., Weickert, M. O., Hartmann, M. F., Schulte, H. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0714 · Cited by 61
Self-citationYildizhan, R., Ilhan, G. A., Yildizhan, B., Kolusari, A., Adali, E., & Bugdayci, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.073 · Cited by 60
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59
Ceriello, A., Giugliano, D., Quatraro, A., Marchi, E., Barbanti, M., & Lef�bvre, P. J. (1990) · Diabetologia · doi:10.1007/bf00404044 · Cited by 59
Polycystic Ovary Syndrome in Adolescents: Pathophysiology and Treatment Implications
Pelusi, C., & Pasquali, R. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302040-00001 · Cited by 58
Legro, R. S., Blanche, P. J., Krauss, R. M., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00401-x · Cited by 58
Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis
Løbo, R. A., Skinner, J. B., Lippman, J. S., & Cirillo, S. J. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58321-6 · Cited by 58
Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome
Tan, S., Bechmann, L. P., Benson, S., Dietz, T., Eichner, S., Hahn, S., Janssen, O. E., Lahner, H., Gerken, G., Mann, K., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1834 · Cited by 57
Palomba, S., Orio, F., Falbo, A., Russo, T., Tolino, A., & Zullo, F. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.021 · Cited by 56
Ketel, I. J. G., Stehouwer, C. D. A., Henry, R. M. A., Serné, E. H., Hompes, P. G. A., Homburg, R., Smulders, Y. M., & Lambalk, C. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0868 · Cited by 55
Resistin: a new link between obesity and insulin resistance?
Vidal‐Puig, A., & O’Rahilly, S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01377.x · Cited by 54
Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kalaitzakis, E., Delkos, D., Kandaraki, E., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-330 · Cited by 53
Florakis, D., Diamanti‐Kandarakis, E., Katsikis, I., Nassis, G. P., Karkanaki, A., Georgopoulos, N. A., & Panidis, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803777 · Cited by 53
Palomba, S., Falbo, A. I., Russo, T., Rivoli, L., Orio, M., Ag, C., Vero, R., Capula, C., Tolino, A., Zullo, F., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1971 · Cited by 53
Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51
Giallauria, F., Palomba, S., Manguso, F., Vitelli, A., Maresca, L., Tafuri, D., Lombardi, G., Colao, A., Vigorito, C., & Orio, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03004.x · Cited by 51
Cardiometabolic aspects of polycystic ovarian syndrome.
Cho, L. W., Randeva, H. S., & Atkin, S. L. (2007) · PubMed Central · Cited by 50
Self-citationSharma, S. T., Wickham, E. P., & Nestler, J. E. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.373 · Cited by 49
Self-citationPolycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 49
Calès, P., Boursier, J., Chaigneau, J., Lainé, F., Sandrini, J., Michalak, S., Hubert, I., Dib, N., Oberti, F., Bertrais, S., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02314.x · Cited by 49
Lindholm, Å., Bixo, M., Björn, I., Wölner‐Hanssen, P., Eliasson, M., Larsson, A. O., Johnson, O., & Poromaa, I. S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.002 · Cited by 47
Luque‐Ramírez, M., Mendieta-Azcona, C., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.082 · Cited by 46
An RCT of metformin versus orlistat for the management of obese anovulatory women
Metwally, M., Amer, S. A. K. S., Li, T. C., & Ledger, W. J. (2008) · Human Reproduction · doi:10.1093/humrep/den454 · Cited by 46
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome
Hahn, S., Haselhorst, U., Quadbeck, B., Tan, S., Kimmig, R., Mann, K., & Janssen, O. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02078 · Cited by 44
Serum leptin levels in patients with polycystic ovary syndrome
Telli, M. H., Yildirim, M., & Noyan, V. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02995-3 · Cited by 43
Glueck, C. J., Morrison, J. A., Goldenberg, N., & Wang, P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.005 · Cited by 43
Oksanen, L., Tiitinen, A., Kaprio, J., Koistinen, H. A., Karonen, S., & Kontula, K. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.10.873 · Cited by 43
Seaman, H. E., de Vries, C. S., & Farmer, R. D. T. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.896 · Cited by 41
Ma, R. C. W., Liu, K. H., Lam, P. M., Cheung, L. P., Tam, W. H., Ko, G. T. C., Chan, M. H. M., Ho, C. S., Lam, C. W. K., Chu, C. W., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1608 · Cited by 40
Preiss, D., Sattar, N., Harborne, L., Norman, J., & Fleming, R. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01825.x · Cited by 39
Self-citationTotal and high–molecular weight adiponectin in women with the polycystic ovary syndrome
Wickham, E. P., Cheang, K. I., Clore, J. N., Baillargeon, J., & Nestler, J. E. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.019 · Cited by 38
Self-citationCardiac flow velocity in women with the polycystic ovary syndrome
Prelević, G. M., Živković, T. B., Balint‐Peric, L., & Ginsburg, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb00534.x · Cited by 38
Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 38
Targher, G., Solagna, E., Tosi, F., Castello, R., Spiazzi, G., Zoppini, G., Muggeo, M., Day, C., & Moghetti, P. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345743 · Cited by 38
Polycystic ovary syndrome in adolescents.
Kent, S. C., & Legro, R. S. (2002) · PubMed · Cited by 38
Anaforoğlu, İ., Algün, E., İnceçayır, Ö., & Ersoy, K. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0019 · Cited by 36
Trolle, B., Lauszus, F. F., Frystyk, J., & Flyvbjerg, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.057 · Cited by 36
Pamuk, B. Ö., Torun, A. N., Kulaksızoğlu, M., Ertuğrul, D. T., Çiftçi, Ö., Kulaksızoğlu, S., Yıldırım, E., & Demirağ, N. G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.073 · Cited by 36
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
Lopez, L. M., Grimes, D. A., & Schulz, K. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006133.pub3 · Cited by 36
Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
Ricardo Benítez, M., Sir‐Petermann, T., Alberto Palomino, A., Bárbara Angel, B., Manuel Maliqueo, Y., Francisco Pérez, B., & Calvillán, M. (2001) · Revista médica de Chile · doi:10.4067/s0034-98872001000700001 · Cited by 35
Glucagon Suppression of Ghrelin Secretion Is Exerted at Hypothalamus-Pituitary Level
Arafat, A. M., Perschel, F. H., Otto, B., Weickert, M. O., Rochlitz, H. J., Schöfl, C., Spranger, J., Möhlig, M., & Pfeiffer, A. F. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0225 · Cited by 35
Self-citationMetabolic syndrome and cardiometabolic risk in PCOS
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0012-8 · Cited by 35
Tsilchorozidou, T., Batterham, R. L., & Conway, G. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03285.x · Cited by 34
Legro, R. S., Urbanek, M., Kunselman, A. R., Leiby, B. E., & Dunaif, A. E. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03153-9 · Cited by 33
Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes
Pusalkar, M., Meherji, P. K., Gokral, J., Savardekar, L., Chinnaraj, S., & Maitra, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487586 · Cited by 33
Giallauria, F., Orio, F., Lombardi, G., Colao, A., Vigorito, C., Tafuri, M., & Palomba, S. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-3 · Cited by 32
The current status of polycystic ovary syndrome
Kovacs, G., & Wood, C. E. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01296.x · Cited by 32
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31
Self-citationInsulin Resistance: Cause or Consequence of Nonalcoholic Steatohepatitis?
Ahima, R. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.048 · Cited by 31
Sattar, N. A., & Fleming, R. (2005) · Wiley eBooks · doi:10.1002/0470025131.ch12 · Cited by 29
Self-citationTopçu, S., Tok, D., Çalışkan, M., Özçimen, E. E., Güllü, H., Üçkuyu, A., Erdoğan, D., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02551.x · Cited by 27
Serum visfatin in Asian women with polycystic ovary syndrome
Jongwutiwes, T., Lertvikool, S., Leelaphiwat, S., Rattanasiri, S., Jultanmas, R., & Weerakiet, S. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015478 · Cited by 26
Premicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker
Patel, A. A., Bloomgarden, Z. T., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.193 · Cited by 24
Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism
Koebnick, C., Wagner, K., García, A. L., Gruendel, S., Lahmann, P. H., Weickert, M. O., Möhlig, M., Harsch, I. A., Einig, C., Speth, M., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803242 · Cited by 23
Self-citationTrakakis, E., Balanika, A. P., Baltas, C. S., Loghis, C., Simeonidis, G., Vaggopoulos, V., Papakonstantinou, O., Gouliamos, A. D., Salamalekis, G., & Kassanos, D. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345639 · Cited by 21
Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters
Joharatnam, J., Barber, T. M., Webber, L. J., Conway, G. S., McCarthy, M. I., & Franks, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03983.x · Cited by 20
Tan, B. K., Adya, R., Shan, X., Aghilla, M., Lehnert, H., Keay, S. D., & Randeva, H. S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.069 · Cited by 18
Self-citationIşık, S., Özcan, H. N., Özuğuz, U., Berker, D. S., Tütüncü, Y., Akbaba, G., & Güler, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04210.x · Cited by 17
Weickert, M. O., Hodges, P., Tan, B. K., et al. (2012) · PubMed · Cited by 15
Self-citationLee-Chiong, T. L., & Polnitsky, C. A. (2007) · Elsevier eBooks · doi:10.1016/b978-075067563-5.10004-5 · Cited by 15
(2000) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(00)00275-3 · Cited by 15
Yasmin, E., Glanville, J., Barth, J. H., & Balen, A. H. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.12.041 · Cited by 14
Is metformin the treatment of choice for anovulation in polycystic ovary syndrome?
Balen, A. H. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0511 · Cited by 12
Iuorno, M. J., Islam, L. Z., Veldhuis, P. P., Boyd, D. G., Farhy, L. S., Johnson, M. L., Nestler, J. E., & Evans, W. S. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.027 · Cited by 12
Self-citationThe American Diabetes Association's 57th Annual Advanced Postgraduate Course
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc11-zb01 · Cited by 12
Sleep Apnea and Neuroendocrine Function
Liu, P. Y., Yee, B. J., Phillips, C. L., & Grunstein, R. R. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.03.008 · Cited by 12
Leukocytosis and hyperleptinemia in obesity: is there a link?
Perfetto, F., Mancuso, F., & Tarquini, R. (2002) · PubMed · Cited by 12
Black, N., & Bell, P. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0550-7 · Cited by 9
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease
Gan, S. K., Adams, L. A., & Watts, G. F. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328317cc42 · Cited by 6
Sattar, N. A. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch16 · Cited by 3
Self-citationIşık, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04255.x · Cited by 1
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Anagnostis, P., Tarlatzis, B. C., & Kauffman, R. P. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.016 · Cited by 416
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
Metadata
- Authors
- Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K., Nestler, J. E., Sattar, N., & Lehnert, H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-07-24
- Volume
- 33
- Issue
- 5
- Pages
- 812-841
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2171871916
- Cited by
- 322
- References
- 327
- FWCI
- 25.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.